CALR and cancer: This new knowledge that CRT binds to asialoglycoproteins, which are often hidden by sialic acid, is the first step in dissecting the mechanism of PrCR initiation, which can be targeted in disease states such as cancer alone, or in combination with CD47 inhibition.